Thermo Fisher Scientific Inc. (TMO) stock
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3035% above fair value
$699.44−18.27 (-2.55%)
Close on Nov 12, 2026Market cap $259.15BP/E 36.9Yield 0.25%
Thermo Fisher Scientific ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Thermo Fisher Scientific's ebitda for the twelve months ending Dec 31, 2018 was $6.05B, up 21.2% year over year. For fiscal 2018 it was $6.05B, up 21.2% from the year before. Over ten years it grew 11.6% a year on average. The highest annual figure on record is $6.05B in fiscal 2018.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $6.05B | +21.2% |
| FY2017 | Dec 31, 2017 | $4.99B | +18.4% |
| FY2016 | Dec 31, 2016 | $4.22B | +4.8% |
| FY2015 | Dec 31, 2015 | $4.02B | -3.9% |
| FY2014 | Dec 31, 2014 | $4.19B | +60.5% |
| FY2013 | Dec 31, 2013 | $2.61B | +5.8% |
| FY2012 | Dec 31, 2012 | $2.47B | +16.8% |
| FY2011 | Dec 31, 2011 | $2.11B | +9.5% |
| FY2010 | Dec 31, 2010 | $1.93B | +9.2% |
| FY2009 | Dec 31, 2009 | $1.77B | -12.7% |
| FY2008 | Dec 31, 2008 | $2.02B | +16.8% |
| FY2007 | Dec 31, 2007 | $1.73B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2018 | Dec 31, 2018 | $1.71B | +11.4% |
| Q3 FY2018 | Sep 29, 2018 | $1.48B | +28.1% |
| Q2 FY2018 | Jun 30, 2018 | $1.51B | +23.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.36B | +25.4% |
| Q4 FY2017 | Dec 31, 2017 | $1.53B | +23.9% |
| Q3 FY2017 | Sep 30, 2017 | $1.15B | – |
| Q2 FY2017 | Jul 1, 2017 | $1.23B | – |
| Q1 FY2017 | Apr 1, 2017 | $1.09B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.24B | – |
See a number that looks wrong?